Cerebral palsy and intrauterine growth

Stephen Jarvis1, Svetlana V Glinianaia, Eve Blair

  • 1Institute of Child Health, School of Clinical Medical Services, University of Newcastle, Newcastle upon Tyne, UK. s.n.jarvis@ncl.ac.uk

Insights

Cerebral palsy risk increases for infants significantly lighter or heavier than optimal birth weight. Risk patterns differ by infant sex and case severity, suggesting potential antenatal factors influencing fetal development.

Area of Science:

  • Neonatalogy
  • Neurology
  • Developmental Pediatrics

Background:

  • Cerebral palsy (CP) is a leading cause of childhood motor disability.
  • Intrauterine growth, assessed via birth weight for gestational age, is a key indicator of fetal well-being.
  • The relationship between abnormal fetal growth and CP risk requires further elucidation.

Purpose of the Study:

  • To examine the association between birth weight for gestation and cerebral palsy prevalence.
  • To investigate sex-specific and severity-specific risk patterns of cerebral palsy related to intrauterine growth.
  • To explore the implications of intrauterine growth monitoring for predicting fetal health and CP risk.

Main Methods:

  • Utilized birth weight for gestational age as a proxy for intrauterine growth.
  • Analyzed the prevalence of cerebral palsy across a spectrum of infant sizes at birth.
  • Compared risk patterns between male and female infants and across different CP severity levels.

Main Results:

  • Cerebral palsy prevalence exhibited a reversed J-shaped relationship with birth weight for gestation.
  • Significantly elevated risks were observed for infants both lighter and heavier than the optimal size.
  • Distinct patterns of size-at-birth specific CP risk were identified for males versus females and for severe versus milder CP cases.

Conclusions:

  • Abnormal intrauterine growth, indicated by deviations in birth weight for gestation, is strongly associated with increased cerebral palsy risk.
  • Sex and CP severity modify the relationship between fetal growth and neurodevelopmental outcomes.
  • Serial monitoring of intrauterine growth may serve as a valuable clinical tool for assessing fetal health and identifying at-risk infants.